A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Compare the Efficacy and Safety of Romosozumab With Placebo in Men With Osteoporosis
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Compare the Efficacy and Safety of Romosozumab With Placebo in Men With Osteoporosis
The study is designed to evaluate if treatment with romosozumab once a month for 12 months compared with placebo is effective in increasing bone mineral density (BMD) at the lumbar spine. Additionally, the study will assess the effect of treatment with romosozumab for 12 months compared with placebo on BMD at the femoral neck and total hip.
Inclusion Criteria:
Exclusion Criteria:
Bogota, Cundinamarca 11001000, Colombia
Ostrava-Trebovice, 722 00, Czechia
Praha 11 - Chodov, 148 00, Czechia
Mizunami-shi, Gifu 509-6134, Japan
Bungoono-shi, Oita Prefecture 879-7125, Japan
Takatsuki-shi, Osaka 569-1123, Japan
Hachioji-shi, Tokyo 192-0046, Japan
Shinagawa-ku, Tokyo 140-0011, Japan
Toshima-ku, Tokyo 171-0033, Japan